Invivyd Aligns with U.S. FDA on Rapid Pathway to Full Approval (BLA) of Vaccine Alternative Monoclonal Antibody VYD2311 to Protect American Adults and Adolescents from COVID-19 ...

Dr Vinay Prasad will return to head the FDA’s Center for Biologics Evaluation and Research less than 2 weeks after being ousted.

FDA authorizes COVID-19 vaccine for children 5 to 11 Following Food and Drug Administration authorization, if the Centers for Disease Control and Prevention greenlights the Pfizer vaccine ...

Insmed received FDA clearance for the first treatment for a chronic lung disease, opening the way to what could be a ...

The uncertainty surrounds who will be able to get updated vaccines in coming months – shots created to protect against more ...

Vinay Prasad, MD, former head of the FDA’s vaccine and gene therapy division who resigned under political pressure two weeks ago, is returning to the agency, The New York Times reported Aug. 9. Dr.

Vinay K. Prasad, MD, MPH, a controversial hematologist-oncologist who abruptly left his two leadership roles at FDA last ...

Vinay Prasad is once again head of the FDA’s Center for Biologics Evaluation and Research, after Laura Loomer led a campaign ...